1. Home
  2. NPWR vs PCRX Comparison

NPWR vs PCRX Comparison

Compare NPWR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPWR
  • PCRX
  • Stock Information
  • Founded
  • NPWR 2010
  • PCRX 2006
  • Country
  • NPWR United States
  • PCRX United States
  • Employees
  • NPWR N/A
  • PCRX N/A
  • Industry
  • NPWR Industrial Machinery/Components
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPWR Energy
  • PCRX Health Care
  • Exchange
  • NPWR Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • NPWR 148.7M
  • PCRX 1.2B
  • IPO Year
  • NPWR N/A
  • PCRX 2011
  • Fundamental
  • Price
  • NPWR $2.46
  • PCRX $24.02
  • Analyst Decision
  • NPWR Buy
  • PCRX Buy
  • Analyst Count
  • NPWR 2
  • PCRX 9
  • Target Price
  • NPWR $4.00
  • PCRX $29.89
  • AVG Volume (30 Days)
  • NPWR 2.4M
  • PCRX 526.9K
  • Earning Date
  • NPWR 08-11-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • NPWR N/A
  • PCRX N/A
  • EPS Growth
  • NPWR N/A
  • PCRX N/A
  • EPS
  • NPWR N/A
  • PCRX N/A
  • Revenue
  • NPWR $250,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • NPWR $308.00
  • PCRX $7.54
  • Revenue Next Year
  • NPWR $1,811.08
  • PCRX $10.78
  • P/E Ratio
  • NPWR N/A
  • PCRX N/A
  • Revenue Growth
  • NPWR 100.00
  • PCRX 3.08
  • 52 Week Low
  • NPWR $1.48
  • PCRX $11.16
  • 52 Week High
  • NPWR $14.28
  • PCRX $29.33
  • Technical
  • Relative Strength Index (RSI)
  • NPWR 52.92
  • PCRX 36.83
  • Support Level
  • NPWR $1.99
  • PCRX $23.85
  • Resistance Level
  • NPWR $2.34
  • PCRX $25.16
  • Average True Range (ATR)
  • NPWR 0.29
  • PCRX 0.79
  • MACD
  • NPWR -0.02
  • PCRX -0.12
  • Stochastic Oscillator
  • NPWR 39.11
  • PCRX 8.20

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: